AKAP9
protein-codingA-kinase anchoring protein 9, the group of A-kinase anchoring proteins|Protein phosphatase 1 regulatory subunits
Gene summary
The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. This gene encodes a member of the AKAP family. Alternate splicing of this gene results in at least two isoforms that localize to the centrosome and the Golgi apparatus, and interact with numerous signaling proteins from multiple signal transduction pathways. These signaling proteins include type II protein kinase A, serine/threonine kinase protein kinase N, protein phosphatase 1, protein phosphatase 2a, protein kinase C-epsilon and phosphodiesterase 4D3. [provided by RefSeq, Aug 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~169.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0018393
Submitter: King Faisal Specialist Hospital and Research Center
Alhathal et al., 2020 (PMID: 32719396) reported a missense variant in a large male infertility cohort (n=285 infertile man and case–control fertile man). The gene is scored according to ClinGen classification. Moderate with total score of 8. Single-variant analysis (3 points), experimental evidence: Animal model (4 points) and testicular expression (1 points) (PMID: 23608191).
Inheritance Pattern: AD
Disease ID:MONDO:0012738
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0002442
Submitter: ClinGen
AKAP9 encodes A-kinase anchor protein 9, a scaffold protein that binds to the slowly activating cardiac potassium channel (Iks) and is important for its physiological response to sympathetic stimulation. The first study to associate this gene with LQTS used a candidate gene approach and identified a missense variant in AKAP9 in a single patient with LQTS (PMID 18093912). However, because of the candidate gene approach, lack of segregation or case-control data and paucity of additional genetic and experimental data, this gene-disease association was classified as disputed. Note: All LQTS genes were curated by 3 separate blinded teams. The evidence and scores reached by these 3 teams were reviewed by the LQTS Clinical Domain Expert Panel. For a detailed discussion of this group's work and the separate scores of the 3 teams please see "Adler et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141(6):418-428. doi: 10.1161/CIRCULATIONAHA.119.043132”
Inheritance Pattern: AD
Disease ID:MONDO:0002442
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0012738
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: In order to prevent sequelae including syncope, cardiac arrest and sudden death prophylactic use of beta blockers in asymptomatic individuals may be beneficial; ICD may be indicated for individuals refractory to beta-blocker treatment or with history of cardiac arrest; Agents that can contribute to prolonged QT or related dysrhythmias should be avoided, as should activities associated with high stress/intense exertion
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AKAP9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005751.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 19 | 813 | 4 | 836 | ||
| missense | 2 | 1806 | 453 | 9 | 2270 | |
| nonsense | 2 | 57 | 1 | 60 | ||
| start loss | 1 | 1 | ||||
| frameshift | 77 | 1 | 3 | 81 | ||
| splice donor/acceptor (+/-2bp) | 47 | 47 | ||||
| Total | 0 | 4 | 2007 | 1268 | 16 | 3295 |
Highest pathogenic variant AF is 0.0000047886692
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005742.4 | 50 | MANE Select | |
| Ensembl | ENSP00000348573.3 | 50 | MANE Select | |
| RefSeq | NP_001366206.1 | 29 | Standard | |
| RefSeq | NP_671714.1 | 50 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- G Protein Signaling Pathways
- NO-cGMP-PKG mediated Neuroprotection
- Disease
- Signal Transduction
- protein kinase a at the centrosome
Biological Process
- G2/M transition of mitotic cell cycle
- microtubule nucleation
- signal transduction
- negative regulation of adenylate cyclase activity
- chemical synaptic transmission
Molecular Function
- DNA binding
- signaling receptor binding
- protein binding
- potassium channel regulator activity
- protein-containing complex scaffold activity
Cellular Component
- Golgi apparatus
- Golgi stack
- cis-Golgi network
- centrosome
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356239
- Coding exons
- 50
- Length
- 169807
- Individuals with no LoFs
- 125545
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 203
- Defined
- 125748
- p
- 0.000807
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.128 | 1850 | 1.83e+3 | 1.01 | 0.0000895 | 25902 |
| Missense (PolyPhen) | 588 | 654.49 | 0.89841 | 9778 | ||
| Synonymous | 0.762 | 625 | 650 | 0.962 | 0.0000317 | 6822 |
| Loss of Function | 9.06 | 71 | 214 | 0.332 | 0.0000115 | 2680 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00062 | 0.00062 | rare |
| Latino/Admixed American | 0.00075 | 0.00075 | rare |
| Ashkenazi Jewish | 0.00021 | 0.00020 | rare |
| East Asian | 0.00049 | 0.00049 | rare |
| Finnish | 0.0012 | 0.0012 | notable |
| European (Non-Finnish) | 0.00096 | 0.00095 | rare |
| South Asian | 0.00073 | 0.00072 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus (PubMed:10202149, PubMed:15047863). Required for microtubule nucleation at the cis-side of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (PubMed:25657325). In complex with PDE4DIP isoform 13/MMG8/SMYLE, recruits CAMSAP2 to the Golgi apparatus and tethers non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745, PubMed:28814570). In complex with PDE4DIP isoform 13/MMG8/SMYLE, EB1/MAPRE1 and CDK5RAP2, contributes to microtubules nucleation and extension also from the centrosome to the cell periphery (PubMed:29162697). {ECO:0000269|PubMed:10202149, ECO:0000269|PubMed:15047863, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:25657325, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28814570, ECO:0000269|PubMed:29162697}.;
- Disease
- DISEASE: Long QT syndrome 11 (LQT11) [MIM:611820]: A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy. {ECO:0000269|PubMed:18093912}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- LoFtool
- 0.933
- RVIS EVS
- 0.22
- RVIS percentile EVS
- 68.45
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.444
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |